全文获取类型
收费全文 | 20608篇 |
免费 | 2146篇 |
国内免费 | 1141篇 |
专业分类
耳鼻咽喉 | 218篇 |
儿科学 | 232篇 |
妇产科学 | 377篇 |
基础医学 | 2422篇 |
口腔科学 | 407篇 |
临床医学 | 2858篇 |
内科学 | 2969篇 |
皮肤病学 | 296篇 |
神经病学 | 1011篇 |
特种医学 | 592篇 |
外国民族医学 | 8篇 |
外科学 | 2164篇 |
综合类 | 3337篇 |
现状与发展 | 2篇 |
一般理论 | 11篇 |
预防医学 | 1222篇 |
眼科学 | 544篇 |
药学 | 2259篇 |
25篇 | |
中国医学 | 1074篇 |
肿瘤学 | 1867篇 |
出版年
2024年 | 88篇 |
2023年 | 453篇 |
2022年 | 845篇 |
2021年 | 1319篇 |
2020年 | 984篇 |
2019年 | 836篇 |
2018年 | 874篇 |
2017年 | 792篇 |
2016年 | 604篇 |
2015年 | 1046篇 |
2014年 | 1222篇 |
2013年 | 1178篇 |
2012年 | 1604篇 |
2011年 | 1655篇 |
2010年 | 1038篇 |
2009年 | 815篇 |
2008年 | 986篇 |
2007年 | 982篇 |
2006年 | 923篇 |
2005年 | 888篇 |
2004年 | 619篇 |
2003年 | 585篇 |
2002年 | 431篇 |
2001年 | 400篇 |
2000年 | 394篇 |
1999年 | 458篇 |
1998年 | 270篇 |
1997年 | 267篇 |
1996年 | 185篇 |
1995年 | 172篇 |
1994年 | 134篇 |
1993年 | 98篇 |
1992年 | 114篇 |
1991年 | 86篇 |
1990年 | 76篇 |
1989年 | 62篇 |
1988年 | 88篇 |
1987年 | 74篇 |
1986年 | 45篇 |
1985年 | 43篇 |
1984年 | 22篇 |
1983年 | 20篇 |
1982年 | 14篇 |
1981年 | 11篇 |
1980年 | 7篇 |
1979年 | 28篇 |
1978年 | 9篇 |
1975年 | 8篇 |
1974年 | 8篇 |
1972年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 625 毫秒
21.
同步放化疗是不可手术局部晚期食管癌的标准治疗模式,国际推荐根治性放疗剂量为50.0~50.4Gy,但中国食管癌与西方国家在病理类型、生物学行为等方面大有不同,行根治性放疗剂量仍倾向于60Gy。增加放疗剂量能否带来生存获益成为临床亟待解决的问题。有研究认为高剂量放疗可提高局控率、改善生存,但也有研究认为提高剂量未能带来生存获益,且可增加不良反应事件发生率。因此,本文就食管癌根治性放疗剂量对预后的影响进行探讨,并通过放化疗后疗效评估对放疗剂量做出适当调整,以期达个体化放疗。 相似文献
22.
目的:探讨电子线对胰岛素生长因子-1家族蛋白表达的影响,为研究辐射对肝脏的早期损伤提供依据。方法:采用电子线照射小鼠,照射剂量为1、2、4 Gy,用Western blot法检测照射后12、48和72 h小鼠肝脏中胰岛素生长因子1受体(IGF-1R)、胰岛素生长因子结合蛋白1(IGFBP1)、胰岛素生长因子结合蛋白4(IGFBP4)和胰岛素生长因子1(IGF-1)蛋白表达水平的改变。结果:照射剂量为1 Gy时,与对照组相比,IGF-1蛋白在照射后48 h时表达增加,IGFBP1、IGFBP4和IGF1R蛋白的表达在照射后12、48和72 h均表达减少。照射剂量为2 Gy时,IGF-1和IGFBP4蛋白在照射后48 h时表达增加,其余时间点表达减少。IGFBP1蛋白在照射后12 h时表达增加,48和72 h时表达减少。IGF1R蛋白在照射后3个时间点均呈现为表达减少。照射剂量4 Gy时,肝脏中IGF-1、IGFBP1和IGFBP4蛋白均表达减少,IGF1R蛋白在照射后12 h时表达增加,48、72 h时均表达减少(均为P < 0.05)。结论:电子线照射后小鼠肝脏中胰岛素生长因子-1家族蛋白多以下调表达为主,与前期基因表达的结果相一致,有可能作为反映放射性工作人员早期肝脏损伤的生物标志物之一。 相似文献
23.
24.
Ye Gao Lei Xin Yu-Xin Wang Yuan-Hang Dong Zhuan Liao 《Scandinavian journal of gastroenterology》2020,55(1):105-113
AbstractBackground and aim: Capsule retention is the most common adverse event associated with video capsule endoscopy. The use of double-balloon enteroscopy-assisted capsule endoscope retrieval has been increasingly reported in recent years. However, evidence is limited regarding its success rate, associated factors, and subsequent clinical outcomes.Methods: A systematic review of relevant studies published before January 2019 was performed. Successful retrieval rate and associated factors, rate of endoscopic balloon dilation, and outcomes after double-balloon enteroscopy were summarized and pooled.Results: Within 154 associated original articles, 12 including 150 cases of capsule retrieval by double-balloon enteroscopy were included. The estimated pooled successful retrieval rate was 86.5% (95% confidence interval, 75.6–95.1%). Anterograde approach and capsules retained in the jejunum or trapped by malignant strictures were associated with a higher successful retrieval rate than the retrograde approach (62/83 [74.7%] vs. 10/38 [26.3%], p?<?.001) and capsules retained in the ileum (41/41 [100.0%] vs. 43/58 [74.1%], p?<?.001) or trapped by benign strictures (21/21 [100.0%] vs. 65/83 [78.3%], p?=?.043). Endoscopic balloon dilation was performed in 38.8% (95% confidence interval, 22.3–56.3%) of patients with benign strictures. Two perforations (1.3%) were reported as severe adverse events after double-balloon enteroscopy. A significantly lower surgery rate was found among cases with successful video capsule removal compared with unsuccessful cases (7.2% vs. 38.5%, p?=?.002).Conclusions: Double-balloon enteroscopy is feasible and safe for removing retained video capsule endoscopes, and its use could decrease the need for surgery in patients with benign strictures and facilitate subsequent surgery in patients with malignant strictures. 相似文献
25.
Objective To analyze the early mortality and related risk factors of new hemodialysis patients in Zhejiang province, and provide basis for reducing the death risk of hemodialysis patients. Methods The early mortality and related factors of new hemodialysis patients from January 1, 2010 to June 30, 2018 were retrospectively analyzed using the database of Zhejiang province hemodialysis registration. The early mortality was defined as death within 90 days of dialysis. Cox regression model was used to analyze the related risk factors of the early mortality in hemodialysis patients. Results The mortality was the highest in the first month after dialysis (46.40/100 person year), and gradually stabilized after three months. The early mortality was 25.33/100 person year. The mortality within 120 days and 360 days were 21.40/100 person year and 11.37/100 person year, respectively. The elderly (≥65 years old, HR=1.981, 95%CI 1.319-2.977, P<0.001), primary tumor (HR=3.308, 95%CI 1.137-5.624, P=0.028), combined with tumors (not including the primary tumor, HR=2.327, 95%CI 1.200-4.513, P=0.012), temporary catheter (the initial dialysis pathway, HR=3.632, 95%CI 1.806-7.307, P<0.001), lower albumin (<30 g/L, HR=2.181, 95%CI 1.459-3.260, P<0.001), lower hemoglobin (every 0.01 g/L increase, HR=0.861, 95%CI 0.793-0.935, P=0.001), lower high density lipoprotein (<0.7 mmol/L, HR=1.796, 95%CI 1.068-3.019, P=0.027) and higher C reactive protein (≥40 mg/L, HR=1.889, 95%CI 1.185-3.012, P=0.008) were the risk factors of early death for hemodialysis patients. Conclusions The early mortality of hemodialysis patients is high after dialysis, and gradually stable after 3 months. The elderly, primary tumor, combined with tumors, the initial dialysis pathway, lower albumin, lower hemoglobin, lower high density lipoprotein and higher C reactive protein are the risk factors of early death for hemodialysis patients. 相似文献
26.
27.
目的观察不同剂量帕米磷酸二钠治疗骨转移癌引起疼痛的治疗效果。方法对66例确诊为骨转移癌的患者随机分为大剂量组和常规剂量组,大剂量组予静滴帕米磷酸二钠90mg;常规剂量组予静滴帕米磷酸二钠45mg,均为第1天和第2天连续给药。两组均每4周重复,共两次。结果大剂量组止痛效果及生活质量均优于常规剂量组。两组比较有显著性差异(P<0.01),两组均无严重不良反应。结论大剂量帕米磷酸二钠在止痛、改善患者生活质量方面明显优于常规剂量,且无严重不良反应,值得临床上进一步应用。 相似文献
28.
INTRODUCTION Alzheimer disease can be classified into familial Alzheimer disease (FAD) and sporadic Alzheimer disease (SAD)[1]. Among FAD, ear- ly-onset FAD(EOFAD) is a familialform in which the onset ofsymptoms occurs before the age of 60 to 65 years, an… 相似文献
29.
30.
观察了10项因素对偏瘫病人下肢功能康复的影响,其结果表明:①下肢功能水平;②平衡功能障碍;③足下垂内翻;④髋关节屈曲外旋挛缩;⑤深感觉障碍;⑥疼痛等几项因素对偏瘫病人下肢功能康复有显著的影响。 相似文献